Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing

Fig. 1

The expression level of COL5A2 was upregulated in gastric cancer (GC). a The level of COL5A2 expression in different tumor types analyzed in TIMER2.0. b COL5A2 mRNA levels in GC samples and normal gastric samples. c The expression of COL5A2 in GC samples was significantly higher than that of 27 pairs of non-cancerous adjacent samples (p < 0.001). d High expression of COL5A2 in GC tissues. e Low expression of COL5A2 in normal tissues. The magnification was 400 fold. *, P < 0.05; **, P < 0.01; ***, P < 0.001

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us